Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 42%
Sell 8%
Strong Sell 0%

Bulls say

Henry Schein Inc. has demonstrated strong financial performance, particularly in its Global Technology segment, which achieved a revenue of $173 million and experienced growth rates of 9.7% as reported and 9.0% on a local internal basis. Additionally, the dental equipment revenue surged by 10.6%, further showcasing robust demand within the dental sector. Overall, the growth in both medical products and dental business revenues, along with the anticipation of mid-single-digit growth in adjusted EBITDA for 2025 compared to FY/24, underscores a positive outlook for the company's financial trajectory.

Bears say

Henry Schein Inc. reported a gross margin for the quarter of 30.7%, which fell short of the expectation of 31.6%, reflecting challenges in its distribution and specialty products businesses. Additionally, the company anticipates lower remeasurement gains in 2026 compared to 2025, despite having fully incorporated this into its financial guidance, indicating potential future pressure on profitability. While adjusted EBITDA exceeded expectations at $291 million compared to the forecast of $284 million, the overall unfavorable mix in product offerings raises concerns about sustainable revenue growth and margin stability.

Henry Schein (HSIC) has been analyzed by 12 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 42% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 12 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.